共 7 条
[1]
Cutting edge:regulatory T cells from lung cancer patients directly inhibit autologous T cell prolifera-tion. Woo E Y,Yeh H,Chu C Set al. J Immunol . 2002
[2]
CD4+CD25+regula-tory Tcells suppress tumor immunity but are sensitive to cyclophos-phamide which allows immunotherapy of established tumors to be cur-ative. Ghiringhelli F,Larmonier N,Schmitt Eet al. European Journal of Immunology . 2004
[3]
Crucial role of FoxP3in the development and function of human CD25+CD4+regulatory T cells. Yagi H,Nomura T,Nakamura Ket al. International Immunology . 2004
[4]
Autoreactive human peripheral blood CD8+Tcells with a regulatory phenotype and func-tion. Jarvis L B,Matyszak MK,Duggleby R Cet al. European Journal of Immunology . 2005
[5]
Proportion of CD4+CD25+regulatory T cell is increased in the patients with ovarian carcinoma. Li X,Ye D F,Xie Xet al. Cancer Investigation . 2005
[6]
Increase of regulatory Tcells in the peripheral blood of cancer patients. Wolf A M,Wolf D,Steurer Met al. Clinical Cancer Research . 2003
[7]
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Liyanage UK,Moore TT,Joo HGet al. J Immunol . 2002